BioCentury
ARTICLE | Company News

Medarex and Athersys in antibody deal

August 16, 2000 7:00 AM UTC

Athersys (Cleveland, Ore.) will use its random activation of gene expression (RAGE) proteomics technology to generate 10 disease-related antigen targets and MEDX will use its HuMAb-Mouse technology to...